J. Ford

发表

Computational approaches to parameter estimation and model selection in immunology

C. Baker, G. Bocharov, C. Paul, 2005 .

Pulsar Search Using Supervised Machine Learning

J. Ford, 2017 .

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.

C. Sawyers, H. Kantarjian, J. Ford, 2001, The New England journal of medicine.

Chronic myelogenous leukemia.

M. Baccarani, C. Sawyers, J. Ford, 2001, Hematology. American Society of Hematology. Education Program.

Pharmacokinetics and pharmacodynamics of imatinib in a phase I trial with chronic myeloid leukemia patients.

A. Racine‐Poon, C. Sawyers, J. Ford, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study

M. Cazzola, E. Neufeld, P. Greenberg, 2007, European journal of haematology.

Patient Satisfaction with Deferasirox (Exjade®, ICL670) an Oral Form of Chelation Therapy Versus Deferoxamine an Infused Chelation Therapy.

J. Ford, M. Cappellini, M. Bejaoui, 2005 .

Report of an international expanded access program of imatinib in adults with Philadelphia chromosome positive leukemias.

J. Ford, I. Gathmann, R. Capdeville, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Central Nervous System Failure in Patients with Chronic Myelogenous Leukemia Lymphoid Blast Crisis and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Treated with Imatinib (STI-571)

J. Ford, B. Druker, P. Curtin, 2004, Leukemia & lymphoma.

Regulation of sterol synthesis in leukaemic blast cells: a defect resembling familial hypercholesterolaemia

J. Ford, W. Krone, D. J. Betteridge, 1979, European journal of clinical investigation.

Role of nutraceuticals in dementia care.

J. Ford, N. Brandt, 2014, Journal of gerontological nursing.

Efficacy of mevinolin as adjuvant therapy for refractory familial hypercholesterolaemia.

J. Ford, G. Thompson, I. Trayner, 1986, The Quarterly journal of medicine.

Effect of Food, Type of Food, and Time of Food Intake on Deferasirox Bioavailability: Recommendations for an Optimal Deferasirox Administration Regimen

J. Ford, M. Cappellini, R. Galanello, 2008, Journal of clinical pharmacology.

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.

C. Sawyers, H. Kantarjian, J. Ford, 2001, The New England journal of medicine.

Combined granulocyte and platelet transfusions: inter-relationship between granulocyte and platelet recoveries in the presence and absence of complicating factors.

T. Lister, J. Ford, M. Cullen, 2009, Scandinavian Journal of Haematology.

Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload.

J. Ford, M. Cappellini, R. Galanello, 2006, Haematologica.

Prophylactic granulocyte transfusions: results of a randomized controlled trial in patients with acute myelogenous leukemia

T. Lister, J. Ford, R. Oliver, 1982, Transfusion.

Imatinib treatment: specific issues related to safety, fertility, and pregnancy.

J. Ford, M. Hensley, 2003, Seminars in hematology.

FATAL GRAFT-VERSUS-HOST DISEASE FOLLOWING TRANSFUSION OF GRANULOCYTES FROM NORMAL DONORS

T. Lister, J. Ford, J. Tobias, 1976, The Lancet.

Possible prolongation of remission in acute myeloid leukemia by granulocyte transfusions.

T. Lister, J. Ford, R. Oliver, 1980, The New England journal of medicine.

A Cross‐matching Procedure for the Selection of Platelet Donors for Alloimmunized Patients

T. Lister, J. Ford, R. Bell, 1981, British journal of haematology.

Should Prophylactic Platelets be given to Patients with Acute Leukaemia

J. Ford, 1980 .

Practical management of patients with chronic myeloid leukemia receiving imatinib.

J. Ford, B. Druker, M. Deininger, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Short-term treatment for acute myelogenous leukaemia.

T. Lister, A. Rohatiner, J. Ford, 1982, British medical journal.

Practical M anagement o f P atients W ith C hronic M yeloid Leukemia R eceiving I matinib

J. Ford, B. Druker, 2003 .

Pract ica l Management of Pat ients With Chronic Myelo id Leukemia Receiv ing Imat inib

J. Ford, B. Druker, M. Deininger, 2003 .

Combined granulocyte and platelet transfusions. Development of alloimmunization as reflected by decreasing cell recovery values

T. Lister, J. Ford, R. Oliver, 1982, Transfusion.

Safety of Deferasirox (Exjade®) in Patients with Transfusion-Dependent Anemias and Iron Overload Who Achieve Serum Ferritin Levels <1000 Ng/Ml during Long-Term Treatment

J. Ford, M. Cappellini, A. Piga, 2008 .

Summary of Long-Term Renal Safety Data in Transfused Patients with Secondary Iron Overload Receiving Deferasirox (Exjade®, ICL670).

J. Ford, E. Glimm, C. Ponticelli, 2006 .

Deferasirox (Exjade®, ICL670) Demonstrates Iron Chelating Efficacy Related to Transfusional Iron Intake in Pediatric Patients.

J. Ford, T. Klingebiel, Y. Kilinç, 2005 .

Impact of Dose Adjustments on Serum Ferritin (SF) Levels during Long-Term Treatment with Once-Daily, Oral Deferasirox (Exjade®, ICL670).

J. Ford, M. Cappellini, A. Cohen, 2007 .

Failure of oral pamidronate to reduce skeletal morbidity in multiple myeloma: a double‐blind placebo‐controlled trial

J. Ford, N. Abildgaard, I. Turesson, 1998, British journal of haematology.

Iron Chelation Therapy with Deferasirox (Exjade®, ICL670) or Deferoxamine Results in Reduced Hepatocellular Inflammation and Improved Liver Function in Patients with Transfusion-Dependent Anemia.

J. Ford, P. Brissot, A. Thompson, 2005 .

Semi-Quantitative Assessment of Hemosiderin Distribution Accurately Reflects Reductions in Liver Iron Concentration Following Therapy with Deferasirox (Exjade®, ICL670) or Deferoxamine in Patients with Transfusion-Dependent Anemia.

J. Ford, H. Cario, E. Vichinsky, 2005 .

The role of transtracheal aspiration in the diagnosis of respiratory infection in neutropenic patients with acute leukaemia.

T. Lister, J. Ford, M. Slevin, 1981, Leukemia research.

Combination chemotherapy for advanced non-Hodgkin's lymphoma of unfavourable histology

T. Lister, A. Stansfeld, D. Crowther, 2004, Cancer Chemotherapy and Pharmacology.

PROGNOSIS IN PATIENTS WITH HODGKIN'S DISEASE STAGE IIIA WITH POSITIVE SPLEEN

J. Ford, P. Wrigley, J. Malpas, 1977, The Lancet.